Boston Scientific’s Apex
This article was originally published in The Gray Sheet
Executive Summary
Percutaneous transluminal coronary angioplasty catheter debuts Nov. 10 following PMA approval. The "high performance" device is designed to treat "the most challenging atherosclerotic lesions," and is available in both Monorail and over-the-wire versions, the firm says. In addition, Apex includes two different 1.5 mm designs: The Apex Push Catheter enhances "pushability" for tight lesions, and the Apex Flex Catheter enhances "trackability" for tortuous arteries, Boston Scientific says. The system also includes balloon diameters from 1.5 mm to 5.0 mm, with lengths from 8 mm to 40 mm. Boston Scientific believes Apex will help the company improve its 65% share of the U.S. balloon catheter market